Stent Abbott XIENCE ALPINE

The xience™ des is proven to offer unparalleled patient outcomes during and long after percutaneous coronary interventions (pci).1 with over 20 million implants and studied in 120+ clinical trials,* xience™ stent provides consistent long-term safety data out to 10 years.2 xience™ stent allows interventional cardiologists (ics) to achieve the positive outcomes they want for their patients. Stent choice mattersDuring percutaneous coronary interventions (pci), small differences between stents can be the determining factor for the patient's acute and long-term outcomes.4 xience skypoint™ stent has a number of features that offer broader treatment options to interventional cardiologists (ics). Design features include: Larger stent expansion and enhanced stent design2Slimmer catheter profile with integrated one-piece shaft2Low crossing forces and excellent pushability2,5Improved catheter hub2These features can help clinicians treat the increasingly wide range of lesions encountered in real-world patients. Xience skypoint™ stent retains proven design elementsCompared to other des, several key factors account for xience™ stent's unparalleled clinical outcomes.1 About the Company Legal Status of Firm: Proprietorship Number of Employees: Upto 10 People Annual Turnover: 40 L - 1.5 Cr company-description: Established in the year 2010 at Navi Mumbai, Maharashtra, We "Angus Healthcare" are a Proprietorship based firm, engaged as the foremost Wholesale Distributor of Pharmaceutical Tablets, Energy Drink Powder, Pharmaceutical Syrup.